Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Recognizing trichoscopic features is crucial for diagnosing various hair loss conditions.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Understanding and treating alopecia areata improves patient care.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

Researchers found that hair shedding happens mostly when new hair is growing and involves a unique process.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Scoring systems help doctors assess and treat skin diseases effectively.

Terbinafine can cause hair loss.

The book reveals diverse patterns of hair growth in different species and advancements in hair and alopecia research.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Better hair loss models needed for research.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

More research is needed to confirm the potential of various treatments, including Helichrysum plicatum, vitamins, bromelain, personalized medications, hydrogels, and bacteriophage therapy.

L-Cystine and L-Cystine with Kera-Diet® safely improved hair and nail quality in healthy women.

Skin issues can indicate immune system problems.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Apremilast improved symptoms in patients with severe skin conditions.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.